Quick Summary:
In the rapidly evolving healthcare landscape, the global prosthetic heart valve devices and equipment market is continually pushing boundaries to improve the quality of life for heart patients. Staying on top of current trends and market changes are vital for senior executives making strategic decisions. This comprehensive market research report exclusively focused on the prosthetic heart valve devices and equipment market offers crucial insights needed to make informed choices in an increasingly competitive marketplace.
The report delves into various aspects of the market including technological advancements, market trends, product types, main regions, key players, and regulatory processes - all crucial areas every player needs to understand in order to navigate this complex market successfully. From the rising prevalence of valvular heart disease to the increasing preference for polymer valves, this report equips you with knowledge and foresight to identify opportunities and stay ahead. Tap into the potential of this growing market with this meticulously researched report.
The global prosthetic heart valve devices and equipment market will grow from $5.04 billion in 2022 to $5.5 billion in 2023 at a compound annual growth rate (CAGR) of 9.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services effecting many markets across the globe. The prosthetic heart valve devices and equipment market is expected to grow to $7.41 billion in 2027 at a CAGR of 7.7%.
The prosthetic heart valve devices and equipment market consist of sales of mechanical heart valves, transcatheter heart valves, and tissue heart valves that are used for heart patients. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
Prosthetic heart valve devices and equipment are artificial heart valves that are implanted in the heart of a patient with valvular heart disease.
North America was the largest region in prosthetic heart valve devices and equipment market in 2022. Western Europe was the second-largest region in prosthetic heart valve devices and equipment market. The regions covered in the prosthetic heart valve devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
The main types of prosthetic heart valve devices and equipment are transcatheter heart valve, tissue heart valve, and mechanical heart valve. Transcatheter aortic valve replacement is an invasive heart procedure to replace a thickened aortic valve that will not fully open. The product types are repair products, mitral valve repair devices, and tricuspid valve repair devices. The technologies involved in prosthetic heart valve devices and equipment are biological valves and decellularized valves that are used in various applications such as hospitals and ambulatory surgery centres.
The rising prevalence of valvular heart disease has driven the need for transcatheter aortic valve replacement (TAVR) procedures, thus driving the prosthetic heart valve devices and equipment market. TAVR is a minimally-invasive surgical procedure done to cure aortic stenosis which is a valvular heart disease that affects the aortic valve of the heart. Aortic stenosis affects the aortic valve by hardening it, thus not allowing blood to properly flow through it and TAVR is used to replace this defective aortic valve with a transcatheter valve. According to a report from The Society of Thoracic Surgeons (STS)/American College of Cardiology (ACC) TVT Registry, volumes have grown every year. In 2021, TAVR procedures make up more than 84% of aortic valve replacement procedures in the united states. 92,000 TAVR procedures were done in 2021. As the rate of occurrence of valvular heart diseases rises, the number of TAVR procedures done can be expected to increase which also increases the demand for transcatheter valves, thus driving the market going forward.
Prosthetic heart valve devices have stringent procedures for approval which restrains the growth of the prosthetic heart valve devices and equipment market. According to the US food and drugs administration (FDA), randomized clinical trials are required for any medical device, to test for its safety standards. A randomized clinical trial is a clinical method of study that involves the separation of groups of patient subjects using random selection. This is done to compare different medicines and treatment methods fairly with no room for bias and also to detect side effects if any. However, these random clinical trials take long periods.
Companies in this market are increasingly preferring polymer valves over traditional mechanical and bio-prosthetic valves/tissue valves. Polymer heart valves are prosthetic heart valves made of polymeric materials and have better functioning than tissue and mechanical heart valves. Mechanical heart valves come with a lifelong requirement of using blood-thinning medication to prevent blood clotting whereas bioprosthetic heart valves come with a short life span that needs several replacements and have a risk of valve degradation. Polymeric heart valves on the other hand support better blood flow and reduce the risk of blood clotting and therefore do not have the disadvantages of tissue and mechanical valves. Therefore, various companies are focusing on the development of polymeric heart valve technologies, For instance, in July 2022, Shanghai Medics, a Shanghai-based medical technology company developed new synthetic heart valve. The new valve is developed using polymer nanomaterial and has a longer lasting life of 20 to 25 years.
The prosthetic heart valve devices and equipment market is monitored by regulatory bodies such as FDA in the US and The Central Drugs Standard Control Organization (CDSCO). For instance, CDSCO issued a notice regarding the classification of the risk levels of different medical devices. Under this classification, prosthetic heart valves are considered a class D or high-risk device. Similarly, for manufacturers to produce and sell prosthetic valve devices in India, they need to sign forms MD-7 and MD-8 which come under the direct purview of the central government of India. Form MD-7 is used to register prosthetic valve manufacturers in India and form MD-8 is used by prosthetic valve manufacturers to apply for loans.
The countries covered in the prosthetic heart valve devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia.
The market value is defined as the revenues that enterprises gain from goods and/or services sold within the specified market and geography through sales, grants, or donations in terms of currency (in USD ($) unless otherwise specified).
The revenues for a specified geography are consumption values - that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced. It does not include revenues from resales either further along the supply chain or as part of other products.
The prosthetic heart valve devices and equipment market research report is one of a series of new reports that provides prosthetic heart valve devices and equipment market statistics, including prosthetic heart valve devices and equipment industry global market size, regional shares, competitors with a prosthetic heart valve devices and equipment market share, detailed prosthetic heart valve devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the prosthetic heart valve devices and equipment industry. This prosthetic heart valve devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Major players in the prosthetic heart valve devices and equipment market are Boston Scientific, Edward life sciences, Medtronic, Livanova, Abbott, Jenavalve technology, Lepu medical, Cryolife, Neovasc Inc, and St. Jude medical.
This product will be delivered within 1-3 business days.
The prosthetic heart valve devices and equipment market consist of sales of mechanical heart valves, transcatheter heart valves, and tissue heart valves that are used for heart patients. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
Prosthetic heart valve devices and equipment are artificial heart valves that are implanted in the heart of a patient with valvular heart disease.
North America was the largest region in prosthetic heart valve devices and equipment market in 2022. Western Europe was the second-largest region in prosthetic heart valve devices and equipment market. The regions covered in the prosthetic heart valve devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
The main types of prosthetic heart valve devices and equipment are transcatheter heart valve, tissue heart valve, and mechanical heart valve. Transcatheter aortic valve replacement is an invasive heart procedure to replace a thickened aortic valve that will not fully open. The product types are repair products, mitral valve repair devices, and tricuspid valve repair devices. The technologies involved in prosthetic heart valve devices and equipment are biological valves and decellularized valves that are used in various applications such as hospitals and ambulatory surgery centres.
The rising prevalence of valvular heart disease has driven the need for transcatheter aortic valve replacement (TAVR) procedures, thus driving the prosthetic heart valve devices and equipment market. TAVR is a minimally-invasive surgical procedure done to cure aortic stenosis which is a valvular heart disease that affects the aortic valve of the heart. Aortic stenosis affects the aortic valve by hardening it, thus not allowing blood to properly flow through it and TAVR is used to replace this defective aortic valve with a transcatheter valve. According to a report from The Society of Thoracic Surgeons (STS)/American College of Cardiology (ACC) TVT Registry, volumes have grown every year. In 2021, TAVR procedures make up more than 84% of aortic valve replacement procedures in the united states. 92,000 TAVR procedures were done in 2021. As the rate of occurrence of valvular heart diseases rises, the number of TAVR procedures done can be expected to increase which also increases the demand for transcatheter valves, thus driving the market going forward.
Prosthetic heart valve devices have stringent procedures for approval which restrains the growth of the prosthetic heart valve devices and equipment market. According to the US food and drugs administration (FDA), randomized clinical trials are required for any medical device, to test for its safety standards. A randomized clinical trial is a clinical method of study that involves the separation of groups of patient subjects using random selection. This is done to compare different medicines and treatment methods fairly with no room for bias and also to detect side effects if any. However, these random clinical trials take long periods.
Companies in this market are increasingly preferring polymer valves over traditional mechanical and bio-prosthetic valves/tissue valves. Polymer heart valves are prosthetic heart valves made of polymeric materials and have better functioning than tissue and mechanical heart valves. Mechanical heart valves come with a lifelong requirement of using blood-thinning medication to prevent blood clotting whereas bioprosthetic heart valves come with a short life span that needs several replacements and have a risk of valve degradation. Polymeric heart valves on the other hand support better blood flow and reduce the risk of blood clotting and therefore do not have the disadvantages of tissue and mechanical valves. Therefore, various companies are focusing on the development of polymeric heart valve technologies, For instance, in July 2022, Shanghai Medics, a Shanghai-based medical technology company developed new synthetic heart valve. The new valve is developed using polymer nanomaterial and has a longer lasting life of 20 to 25 years.
The prosthetic heart valve devices and equipment market is monitored by regulatory bodies such as FDA in the US and The Central Drugs Standard Control Organization (CDSCO). For instance, CDSCO issued a notice regarding the classification of the risk levels of different medical devices. Under this classification, prosthetic heart valves are considered a class D or high-risk device. Similarly, for manufacturers to produce and sell prosthetic valve devices in India, they need to sign forms MD-7 and MD-8 which come under the direct purview of the central government of India. Form MD-7 is used to register prosthetic valve manufacturers in India and form MD-8 is used by prosthetic valve manufacturers to apply for loans.
The countries covered in the prosthetic heart valve devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia.
The market value is defined as the revenues that enterprises gain from goods and/or services sold within the specified market and geography through sales, grants, or donations in terms of currency (in USD ($) unless otherwise specified).
The revenues for a specified geography are consumption values - that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced. It does not include revenues from resales either further along the supply chain or as part of other products.
The prosthetic heart valve devices and equipment market research report is one of a series of new reports that provides prosthetic heart valve devices and equipment market statistics, including prosthetic heart valve devices and equipment industry global market size, regional shares, competitors with a prosthetic heart valve devices and equipment market share, detailed prosthetic heart valve devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the prosthetic heart valve devices and equipment industry. This prosthetic heart valve devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Major players in the prosthetic heart valve devices and equipment market are Boston Scientific, Edward life sciences, Medtronic, Livanova, Abbott, Jenavalve technology, Lepu medical, Cryolife, Neovasc Inc, and St. Jude medical.
This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Prosthetic Heart Valve Devices and Equipment Market
What is the estimated value of the Global Prosthetic Heart Valve Devices and Equipment Market?
What is the growth rate of the Global Prosthetic Heart Valve Devices and Equipment Market?
What is the forecasted size of the Global Prosthetic Heart Valve Devices and Equipment Market?
Who are the key companies in the Global Prosthetic Heart Valve Devices and Equipment Market?
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2023 |
| Forecast Period | 2023 - 2027 |
| Estimated Market Value ( USD | $ 5.5 billion |
| Forecasted Market Value ( USD | $ 7.41 billion |
| Compound Annual Growth Rate | 7.7% |
| Regions Covered | Global |
Table of Contents
1. Executive Summary2. Prosthetic Heart Valve Devices And Equipment Market Characteristics
3. Prosthetic Heart Valve Devices And Equipment Market Trends And Strategies
4. Prosthetic Heart Valve Devices And Equipment Market Trends - Macro Economic Scenario
4.1 COVID-19 Impact On Prosthetic Heart Valve Devices And Equipment Market Trends
4.2 Ukraine-Russia War Impact On Prosthetic Heart Valve Devices And Equipment Market Trends
4.3 Impact Of High Inflation On Prosthetic Heart Valve Devices And Equipment Market Trends
5. Prosthetic Heart Valve Devices And Equipment Market Size And Growth
5.1. Global Prosthetic Heart Valve Devices And Equipment Historic Market, 2017-2022, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Prosthetic Heart Valve Devices And Equipment Forecast Market, 2022-2027F, 2032F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Prosthetic Heart Valve Devices And Equipment Market Segmentation
6.1. Global Prosthetic Heart Valve Devices And Equipment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Transcatheter Heart Valve
- Tissue Heart Valve
- Mechanical Heart Valve
- Hospitals
- Ambulatory Surgery Centres
- Repair Products
- Mitral Valve Repair Devices
- Tricuspid Valve Repair Devices.
- Biological Valve
- Decellularized Valve
7.1. Global Prosthetic Heart Valve Devices And Equipment Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Prosthetic Heart Valve Devices And Equipment Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8. Asia-Pacific Prosthetic Heart Valve Devices And Equipment Market
8.1. Asia-Pacific Prosthetic Heart Valve Devices And Equipment Market Overview
- Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.3. Asia-Pacific Prosthetic Heart Valve Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
9. China Prosthetic Heart Valve Devices And Equipment Market
9.1. China Prosthetic Heart Valve Devices And Equipment Market Overview
9.2. China Prosthetic Heart Valve Devices And Equipment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.3. China Prosthetic Heart Valve Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
10. India Prosthetic Heart Valve Devices And Equipment Market
10.1. India Prosthetic Heart Valve Devices And Equipment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.2. India Prosthetic Heart Valve Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11. Japan Prosthetic Heart Valve Devices And Equipment Market
11.1. Japan Prosthetic Heart Valve Devices And Equipment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.2. Japan Prosthetic Heart Valve Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12. Australia Prosthetic Heart Valve Devices And Equipment Market
12.1. Australia Prosthetic Heart Valve Devices And Equipment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.2. Australia Prosthetic Heart Valve Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13. Indonesia Prosthetic Heart Valve Devices And Equipment Market
13.1. Indonesia Prosthetic Heart Valve Devices And Equipment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.2. Indonesia Prosthetic Heart Valve Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14. South Korea Prosthetic Heart Valve Devices And Equipment Market
14.1. South Korea Prosthetic Heart Valve Devices And Equipment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.2. South Korea Prosthetic Heart Valve Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15. Western Europe Prosthetic Heart Valve Devices And Equipment Market
15.1. Western Europe Prosthetic Heart Valve Devices And Equipment Market Overview
15.2. Western Europe Prosthetic Heart Valve Devices And Equipment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.3. Western Europe Prosthetic Heart Valve Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16. UK Prosthetic Heart Valve Devices And Equipment Market
16.1. UK Prosthetic Heart Valve Devices And Equipment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.2. UK Prosthetic Heart Valve Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17. Germany Prosthetic Heart Valve Devices And Equipment Market
17.1. Germany Prosthetic Heart Valve Devices And Equipment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.2. Germany Prosthetic Heart Valve Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18. France Prosthetic Heart Valve Devices And Equipment Market
18.1. France Prosthetic Heart Valve Devices And Equipment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.2. France Prosthetic Heart Valve Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19. Eastern Europe Prosthetic Heart Valve Devices And Equipment Market
19.1. Eastern Europe Prosthetic Heart Valve Devices And Equipment Market Overview
19.2. Eastern Europe Prosthetic Heart Valve Devices And Equipment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.3. Eastern Europe Prosthetic Heart Valve Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20. Russia Prosthetic Heart Valve Devices And Equipment Market
20.1. Russia Prosthetic Heart Valve Devices And Equipment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.2. Russia Prosthetic Heart Valve Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21. North America Prosthetic Heart Valve Devices And Equipment Market
21.1. North America Prosthetic Heart Valve Devices And Equipment Market Overview
21.2. North America Prosthetic Heart Valve Devices And Equipment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.3. North America Prosthetic Heart Valve Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22. USA Prosthetic Heart Valve Devices And Equipment Market
22.1. USA Prosthetic Heart Valve Devices And Equipment Market Overview
22.2. USA Prosthetic Heart Valve Devices And Equipment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.3. USA Prosthetic Heart Valve Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23. South America Prosthetic Heart Valve Devices And Equipment Market
23.1. South America Prosthetic Heart Valve Devices And Equipment Market Overview
23.2. South America Prosthetic Heart Valve Devices And Equipment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.3. South America Prosthetic Heart Valve Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24. Brazil Prosthetic Heart Valve Devices And Equipment Market
24.1. Brazil Prosthetic Heart Valve Devices And Equipment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.2. Brazil Prosthetic Heart Valve Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25. Middle East Prosthetic Heart Valve Devices And Equipment Market
25.1. Middle East Prosthetic Heart Valve Devices And Equipment Market Overview
25.2. Middle East Prosthetic Heart Valve Devices And Equipment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.3. Middle East Prosthetic Heart Valve Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26. Africa Prosthetic Heart Valve Devices And Equipment Market
26.1. Africa Prosthetic Heart Valve Devices And Equipment Market Overview
26.2. Africa Prosthetic Heart Valve Devices And Equipment Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.3. Africa Prosthetic Heart Valve Devices And Equipment Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27. Prosthetic Heart Valve Devices And Equipment Market Competitive Landscape And Company Profiles
27.1. Prosthetic Heart Valve Devices And Equipment Market Competitive Landscape
27.2. Prosthetic Heart Valve Devices And Equipment Market Company Profiles
27.2.1. Boston Scientific
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Edward lifesciences
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Medtronic
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Livanova
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Abbott
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Key Mergers And Acquisitions In The Prosthetic Heart Valve Devices And Equipment Market
29. Prosthetic Heart Valve Devices And Equipment Market Future Outlook and Potential Analysis
30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Historic And Forecast Inflation Rates
30.4. Research Inquiries
30.5. About the Publisher
30.6. Copyright And Disclaimer
Executive Summary
Prosthetic Heart Valve Devices And Equipment Global Market Report 2023 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on prosthetic heart valve devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Scope
Markets Covered
1) By Type: Transcatheter Heart Valve; Tissue Heart Valve; Mechanical Heart Valve2) By Application: Hospitals; Ambulatory Surgery Centres
3) By Product Type: Repair Products; Mitral Valve Repair Devices; Tricuspid Valve Repair Devices
4) By Technology: Biological Valve; Decellularized Valve
Companies Mentioned: Boston Scientific; Edward lifesciences; Medtronic; Livanova; Abbott
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
A selection of companies mentioned in this report includes:
- Boston Scientific
- Edward lifesciences
- Medtronic
- Livanova
- Abbott
- Jenavalve technology
- Lepu medical
- Cryolife
- Neovasc Inc.
- St. Jude medical
- Symetis
- Braile biomedica
- Colibri heart valve
- TTK Healthcare Ltd.
- Medical Technology est.
- Micro Interventional Devices Inc.
- Medical circle
- On-X Life Technologies Inc.
- Meril Life Sciences Pvt. Ltd.
- Sorin Group
- Commonwealth Edison Company
- Cardiac Dimensions Inc.
- Cardiosolutions Inc.
- Leman Cardiovascular
- MitralSolutions Inc.
Methodology
LOADING...
